The company submitted an application for a seasonal flu vaccine it believes to be a key growth driver in the years ahead.

Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an ...

FILE PHOTO: SOMOS Community Care administers Moderna COVID-19 Vaccine at pop-up site in New York SYDNEY (Reuters) - U.S. drugmaker Moderna Inc will produce millions of mRNA vaccines a year in ...

Collaboration will support Australia with direct access to rapid pandemic response capabilities “We are excited to expand our presence and continue our long-term collaboration with the Australian and ...

(Reuters) - Moderna Inc said late on Monday Australia's drug regulator Therapeutic Goods Administration (TGA) has provisionally approved its mRNA COVID-19 vaccine, Spikevax, for use in children aged ...

Australia will partner with Moderna Inc. to manufacture tens of millions of vaccine doses domestically, including Covid-19 mRNA shots, as the country seeks to bolster its pharmaceutical supply lines.

The country is the first to grant provisional authority for the Moderna vaccine to be used in children younger than 12. By Matthew Mpoke Bigg Australia’s medicines regulator granted provisional ...

Martin Hensher has received an honorarium from Novartis SA (Brazil) for a lecture delivered to the Novartis Access 2021 conference. He is a member of the South Australian Health Performance Council ...

SYDNEY (Reuters) – U.S. drugmaker Moderna Inc will produce millions of mRNA vaccines a year in Australia after agreeing to set up one of its largest manufacturing facilities outside the United States ...

CAMRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced an agreement in principle with the ...